284 related articles for article (PubMed ID: 688231)
21. Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.
Norgren A; Forsberg AH; Lindgren A; Sällström JF
Anticancer Res; 1989; 9(1):173-6. PubMed ID: 2495752
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
23. Effect of estrogen and progestin treatments on endometria from postmenopausal women.
King RJ; Whitehead MI; Campbell S; Minardi J
Cancer Res; 1979 Mar; 39(3):1094-101. PubMed ID: 427751
[TBL] [Abstract][Full Text] [Related]
24. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
25. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
[TBL] [Abstract][Full Text] [Related]
26. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
27. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth.
Cormier EM; Wolf MF; Jordan VC
Cancer Res; 1989 Feb; 49(3):576-80. PubMed ID: 2783381
[TBL] [Abstract][Full Text] [Related]
28. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
[TBL] [Abstract][Full Text] [Related]
29. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
[TBL] [Abstract][Full Text] [Related]
32. The role of sex steroid receptors in obstetrics and gynecology.
Roberts DK; Van Sickle M; Kelly RW
Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptors and the pattern of relapse in breast cancer.
Qazi R; Chuang JL; Drobyski W
Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
[TBL] [Abstract][Full Text] [Related]
34. Hormone steroid receptor variation after tamoxifen administration in endometrial adenocarcinoma from postmenopausal patients.
Di Fronzo G; Ronchi E; Cappelletti V; Luciani L; Coradini D; Oriana S; Miodini P; Andreola S
Cancer Detect Prev; 1986; 9(3-4):323-30. PubMed ID: 3742507
[TBL] [Abstract][Full Text] [Related]
35. Clinical and experimental aspects of hormone receptors in breast carcinoma patients.
Spona J; Kolb R; Reiner G; Jakesz R; Moser K; Rainer H
Cancer Detect Prev; 1983; 6(1-2):227-34. PubMed ID: 6883382
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers].
Fournier S; Allali F; Durand JC; Sterkers N; Debertrand P; Diebold N; Martin PM; Kuttenn F; Mauvais-Jarvis P
Pathol Biol (Paris); 1985 Jun; 33(6):659-64. PubMed ID: 2995904
[TBL] [Abstract][Full Text] [Related]
37. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
[TBL] [Abstract][Full Text] [Related]
38. [Association between endogenous hormones, hormone receptors and cervical cancer].
Wang JT; Gao ES; Ding L; Cheng YY; Yan JW
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):494-7. PubMed ID: 17147111
[TBL] [Abstract][Full Text] [Related]
39. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
Lønning PE; Helle H; Duong NK; Ekse D; Aas T; Geisler J
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):31-41. PubMed ID: 19591931
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]